Military Need:
The collection, exchange, and management of life saving combat casualty data to solve errors in communication between Roles of Care.
PATCH
Novel System for Persistent Access to Tactical Casualty Health (PATCH)
Between 2001 and 2011, nearly 90% of combat casualty fatalities occurred prior to reaching a properly equipped medical center, a quarter of which were deemed ‘potentially survivable’. To address these long-standing point-of-injury trauma care issues within the battlefield, the military developed a prehospital trauma management approach known as Tactical Combat Casualty Care (TCCC), significantly reducing the number of preventable deaths in the field.
Unfortunately, less than 10% of the 30,000 casualties in Iraq and Afghanistan had any form of documentation of care in their medical records, TCCC included, leading to a staggering 67% of unanticipated adverse events being attributed to an error in communication between Roles of Care. The effective hand off of medical care documentation to subsequent roles of care is imperative to reducing the number of these events.
Vivonics aims to solve this issue by delivering a low/no-power wearable device that accepts, stores, and disseminates previous patient care in a standardized, easy to use manner, regardless of the state of communications. Simple in composition and innovative in design, the proposed system will be a powerful and reliable method to transfer casualty care information on the patient through Roles of Care, regardless of the state of tactical communications.
Disclaimer: The work is supported by the US Army Medical Research and Materiel Command under Contract Number. W81XWH18C0134. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation.
(Award W81XWH18C0134 is titled: Persistent Access to Tactical Casualty Health (PATCH))
To watch a video about PATCH click here!
Product under development, not yet FDA approved
